145 related articles for article (PubMed ID: 36030465)
1. Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
Molho-Pessach V; Hartshtark S; Merims S; Lotem M; Caplan N; Alfassi H; Maly A; Goldstein G; Muskatel RS
Br J Dermatol; 2022 Dec; 187(6):1052-1054. PubMed ID: 36030465
[No Abstract] [Full Text] [Related]
2. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.
Wu D; Wang M; Wang X; Yin N; Song T; Li H; Yu J; Wang DM; Zhao Z
Am J Dermatopathol; 2011 Jun; 33(4):341-4. PubMed ID: 21430505
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
4. Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition.
Martin SB; Polubothu S; Bruzos AL; Kelly G; Horswell S; Sauvadet A; Bryant D; Zecchin D; Riachi M; Michailidis F; Sadri A; Muwanga-Nanyonjo N; Lopez-Balboa P; Knöpfel N; Bulstrode N; Pittman A; Yeh I; Kinsler VA
J Invest Dermatol; 2024 Mar; 144(3):593-600.e7. PubMed ID: 37716647
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
Dessars B; De Raeve LE; El Housni H; Debouck CJ; Sidon PJ; Morandini R; Roseeuw D; Ghanem GE; Vassart G; Heimann P
J Invest Dermatol; 2007 Jun; 127(6):1468-70. PubMed ID: 17301836
[TBL] [Abstract][Full Text] [Related]
6. Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
Krengel S; Widmer DS; Kerl K; Levesque MP; Schiestl C; Weibel L
Br J Dermatol; 2016 Mar; 174(3):642-4. PubMed ID: 26302237
[No Abstract] [Full Text] [Related]
7. Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi.
Papp T; Schipper H; Kumar K; Schiffmann D; Zimmermann R
Melanoma Res; 2005 Oct; 15(5):401-7. PubMed ID: 16179867
[TBL] [Abstract][Full Text] [Related]
8. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
Mochel MC; Hammond MR; Frederick DT; Alora-Palli MB; Piris A; Flaherty KT; Hoang MP
J Am Acad Dermatol; 2015 Sep; 73(3):491-9.e2. PubMed ID: 26190239
[TBL] [Abstract][Full Text] [Related]
9. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
10. The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo.
Hafner C; Stoehr R; van Oers JM; Zwarthoff EC; Hofstaedter F; Klein C; Landthaler M; Hartmann A; Vogt T
J Invest Dermatol; 2009 Nov; 129(11):2730-5. PubMed ID: 19536147
[No Abstract] [Full Text] [Related]
11. Congenital melanocytic naevus syndrome, is there a role for trametinib monotherapy?
Copland E; Pearson B
J Paediatr Child Health; 2023 Apr; 59(4):697-699. PubMed ID: 37010082
[No Abstract] [Full Text] [Related]
12. B-RAF and melanocytic neoplasia.
Gill M; Celebi JT
J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430
[TBL] [Abstract][Full Text] [Related]
13. Giant Congenital Melanocytic Nevus Treated With Trametinib.
Mir A; Agim NG; Kane AA; Josephs SC; Park JY; Ludwig K
Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30792255
[TBL] [Abstract][Full Text] [Related]
14. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.
Yeh I; von Deimling A; Bastian BC
J Natl Cancer Inst; 2013 Jun; 105(12):917-9. PubMed ID: 23690527
[TBL] [Abstract][Full Text] [Related]
15. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
[TBL] [Abstract][Full Text] [Related]
16. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
17. Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage.
De Raeve LE; Claes A; Ruiter DJ; van Muijen GN; Roseeuw D; van Kempen LC
Br J Dermatol; 2006 Mar; 154(3):485-92. PubMed ID: 16445780
[TBL] [Abstract][Full Text] [Related]
18. DDR2 mutation in a spilus-type giant congenital melanocytic nevus.
Gallo-Pineda G; Ortiz-Prieto A; Villegas-Romero I; Navarro-Navarro I; Linares-Barrios M
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e793-e794. PubMed ID: 35620941
[No Abstract] [Full Text] [Related]
19. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
[TBL] [Abstract][Full Text] [Related]
20. Atypical Phacomatosis Pigmentokeratotica as the Expression of a Mosaic RASopathy With the BRAF-Glu586Lys Mutation.
Ayala D; Ramón MD; Martín JM; Jordá E
Actas Dermosifiliogr; 2016 May; 107(4):344-6. PubMed ID: 26703821
[No Abstract] [Full Text] [Related]
[Next] [New Search]